Abstract
The aim of this study is to compare between combined preoperative rectal misoprostol plus perivascular vasopressin and tourniquet to decrease blood loss during abdominal myomectomy. In this randomized study, 104 patients were randomly allocated to receive either combined 400 μg rectal misoprostol plus perivascular vasopressin (n = 52) or tourniquet (n = 52). The main outcome measure was the operative blood loss. Secondary outcome measures included the requirement for blood transfusion, the change in hemoglobin level after operation, and incidence of complications. Blood loss was significantly greater in the group with tourniquet (375.7 ± 292.3 mL) than in the group with rectal misoprostol plus perivascular vasopressin (254.1 ± 185.4 mL) (P = 0.03). The group with tourniquet had a significant decrease in Hb level 24 h after operation (P < 0.04). Blood transfusion rate was significantly greater in the group with tourniquet (P < 0.04). The febrile morbidity was comparable in the two groups. Rectal misoprostol plus perivascular vasopressin was found to be more effective than tourniquet for decreasing blood loss during abdominal myomectomy.
Similar content being viewed by others
References
Buttram VC Jr, Reiter RC (1981) Uterine leiomyomata: etiology, symptomatology, and management. Fertil Steril 36(4):433–445
Vercellini P, Vendola N, Ragni G, Trespidi L, OldaniS CPG (1993) Abnormal uterine bleeding associated with iron-deficiency anemia: etiology and role of hysteroscopy. J Reprod Med 38:502–504
Verkauf BS (1993) Changing trends in treatment of leiomyomata uteri. Curr Opin Obstet Gynecol 5(3):301–310
Garcia CR (1993) Management of the symptomatic fibroid in women older than 40 years of age. Hysterectomy or myomectomy? Obstet Gynecol Clin North Am 20(2):337–348
Lethaby A, Vollenhoven B, Sowter M (2001) Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids. Cochrane Data base Syst Rev 2:CD000547
Mukhopadhaya N, DeSilv C, ManyondaI T (2008) Conventional myomectomy. Best practice and research Clinical. Obstet Gynecol 22:677–705
Rossetti A, Paccosi M, Sizzi O, Zulli S, Mancuso S, Lanzone A (1999) Dilute ornitin vasopressin and a myomadrill for laparoscopic myomectomy. J Am Assoc Gynecol Laparosc 6(2):189–193
Wing DA, Goharkhay N, Felix JC, Rostamkhani M, Naidu YM, Kovacs BW (2006) Expression of the oxytocin and V1a vasopressin receptors in human myometrium in differing physiologic states and following misoprostol administration. Gynecol Obstet Invest 62(4):181–185
Fletcher H, Frederick J, Simeon D, Hardie M (1996) A randomized comparison of vasopressin and tourniquet as hemostatic agents during myomectomy. Obstet Gynecol 87:1014–1018
Taylor A, Sharma A, Tsirkas P, Arora R, De SpiezioSardo A, Mastrogamvrakis G et al (2005) Surgical and radiological management of uterine fibroids—a UK survey of current consultant practice. Acta Obstet Gynecol Scand 84:478–482
Wang CJ, Yuen LT, Han CM, Kay N, Lee CL, Soong YK (2008) A transient blocking uterine perfusion procedure to decrease operative blood loss in laparoscopic myomectomy. Chang Gung Med J 31:463–468
Frederick S, Frederick J, Fletcher H, Reid M, Hardie M, Gardner W (2013) A trial comparing the use of rectal misoprostol plus perivascular vasopressin with perivascular vasopressin alone to decrease myometrial bleeding at the time of abdominal myomectomy. Fertil Steril 100(4):1044–9
NiroomandN HS, Tabrizi MN, Ghajarzadeh M (2015) A single dose of misoprostol for reducing hemorrhage during myomectomy: a randomized clinical trial. Arch Gynecol Obstet 292:155–158
Abdel-Hafeez M, Elnaggar A, Ali M, Ismail AM, Yacoub M (2015) Rectal misoprostol for myomectomy: a randomized placebo-controlled study. Aust N Z J Obstet Gynaecol 55(4):363–368
Sapmaz E, Celik H (2003) Use of a single preoperative dose of misoprostol is efficacious for patients who undergo abdominal myomectomy. Fertil Steril 79:1207–1210
Kashanian M, Vahdat M, Asadollah S, Yazdkhasti P, Nikravan N (2015) The effect of misoprostol on intraoperative blood loss after myomectomy. Int J Reprod Contracept Obstet Gynecol 4(3):776–779
Ragab A, Khaiary M, Badawy A (2014) The use of single versus double dose of intra-vaginal prostaglandin E2 “Misoprostol” prior to abdominal myomectomy. A randomized controlled clinical trial. Reprod Infertil 15(3):152–156
Tang OS, Gemell-Danielson PC (2007) Misoprostol: pharmacokinetics profile of effectson uterus and side effects. Int J Gynecol Obstet 99:5160–5167
Khan RU, El-Refaey H, Sharma S, Sooranna D, Stafford M (2004) Oral, rectal, and vaginal pharmacokinetics of misoprostol. Obstet Gynecol 103:866–870
Frederick J, Fletcher H, Simeon D, Mullings A, Hardie M (1994) Intramyometrial vasopressin as a haemostatic agent during myomectomy. Br J Obstet Gynaecol 101:435–437
Rasmussen H, Schwartz IL, Schoessler MA, Hochst G (1960) Studies on the mechanism of action of vasopressin. Proc Natl Acad Sci U S A 46:1278–1287
Nezhat F, Admon D, Nezhat CH, Dicorpo JE, Nezhat C (1994) Life threatening hypotension after vasopressin injection during operative laparoscopy, followed by uneventful repeat laparoscopy. J Am Assoc Gynecol Laparosc 2:83–86
Alptekin H, Efe D (2014) Effectiveness of pericervical tourniquet by Foley catheter reducing blood loss at abdominal myomectomy. Clin Exp Obstet Gynecol 41(4):440–444
Ikechebelu JI, Ezeama CO, Obiechina NJ (2010) The use of tourniquet to reduce blood loss at myomectomy. Niger J Clin Pract 13(2):154–158
Taylor A, Sharma M, Tsirkas P, DiSpiezioSardo A, Setchell M, Magos A (2005) Reducing blood loss at open myomectomy using triple tourniquets: a randomized controlled trial. BJOG 112:340–345
Kongnyuy EJ, Wiysonge CS. Interventions to reduce haemorrhage during myomectomy for fibroids. Cochrane Database of Syst Rev 2007: CD005355.
Al-Shabibi N, Chapman L, Madari S, Papadimitriou A, Papalampros P, Magos A (2009) Prospective randomised trial comparing gonadotrophin-releasing hormone analogues with triple tourniquets at open myomectomy. BJOG 116(5):681–687
Ginsburg ES, Benson CB, Garfield JM, Gleason RE, Friedman AJ (1993) The effect of operative technique and uterine size on blood loss during myomectomy: a prospective randomized study. Fertil Steril 60(6):956–962
Authors’ contributions
El Sharkwy AI is responsible for the project development, data collection, and manuscript writing.
Lotfy M is responsible for the data collection and manuscript writing.
Abdeldayem MH is responsible for the data collection and manuscript writing.
Abdel Hameed A is responsible for the data collection and manuscript writing.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The current randomized controlled trial was carried out at the Department of Obstetrics and Gynecology, Zagazig University Hospital, Zagazig, Egypt. Approval of the University Ethics Committee was gained.
A written consent was obtained from each women undergoing abdominal myomectomy.
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Synopsis: Rectal misoprostol plus perivascular vasopressin was found to be more effective than pericervical tourniquet for decreasing blood loss during abdominal myomectomy.
Rights and permissions
About this article
Cite this article
El Sharkwy, I.A.E., Lotfy, M., Abdeldayem, H.M. et al. Rectal misoprostol plus perivascular vasopressin versus tourniquet to decrease blood loss during abdominal myomectomy. Gynecol Surg 13, 373–377 (2016). https://doi.org/10.1007/s10397-016-0956-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10397-016-0956-2